CDG Co., Ltd.
CDG Co., Ltd. (2487.T) Stock Overview
Explore CDG Co., Ltd.’s financial performance, market position, analyst ratings, and future outlook.
Key Financials
Key Financials
Market Cap
7.4B
P/E Ratio
19.54
EPS (TTM)
$43.59
ROE
0.06%
2487.T Stock Analysis & Investment Overview
Our comprehensive AI-powered analysis of CDG Co., Ltd. (2487.T) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B+, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.
The current technical analysis reveals key indicators including an RSI of 17.64, suggesting the stock is in an oversold condition. Our forecasting models predict significant price movements, with a 12-month target of $1542.62.
Key financial metrics showcase the company's fundamental strength, including a P/E ratio of 19.54 and a market capitalization of 7.4B. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.
Technical Indicators
Company Profile
CDG Co., Ltd. provides marketing communication services in Japan. The company also plans and executes sales promotion marketing, and client's overall business operation solutions; and manufactures and sells pocket tissue products. The company's clients include companies operating in various industries, such as energy, materials, and machinery; real estate and housing; food; publication; beverages, alcohol, and tobacco; data management and communication; pharmaceutical and medical supply; distribution and retail; cosmetics and toiletries; finance and insurance; fashion; transportation and leisure; precision instruments and office supply; food service and other services; home electric appliances and AV equipment; government and local organizations; automotive; education, medical service, and religion; household products; tourism; and hobby and sporting goods. CDG Co., Ltd. was incorporated in 1974 and is headquartered in Osaka, Japan.
Hideo Konishi
269
HERBIS ENT, Osaka
2006